Pfizer’s COVID Cash Powers A ‘Marketing Machine’ On The Hunt For New Supernovas
Pfizer is sinking billions in profits from COVID-19 into developing and marketing potential new treatment blockbusters for conditions like migraines, sickle cell disease and obesity.